This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Momenta Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jocelyn H. Leu and Patent Innovation in Myasthenia Gravis Treatment.
Introduction
Jocelyn H. Leu is an inventor associated with Spring House, Pennsylvania, and Momenta Pharmaceuticals, Inc. Her patent work includes an invention concerning anti-FcRn antibodies and potential treatment approaches for myasthenia gravis.
Latest Patents
The listed patent, “Anti-FcRn Antibodies and Methods for Treating Myasthenia Gravis,” addresses antibodies targeting the neonatal Fc receptor (FcRn) and methods related to treating myasthenia gravis. The supplied information credits Leu with 1 patent.
Career Highlights
Leu’s listed patent reflects work in biotechnology and therapeutic development, particularly research focused on antibody-based approaches to an autoimmune neuromuscular disorder. The provided information associates her with Momenta Pharmaceuticals, Inc.
Collaborations
Sindhu Ramchandren and Hong Sun are identified as Leu’s coworkers. Their names appear alongside her in the supplied information about her professional connections.
Conclusion
Jocelyn H. Leu’s listed patent connects her work at Momenta Pharmaceuticals with research into anti-FcRn antibodies and potential treatments for myasthenia gravis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile